Cite

HARVARD Citation

    Flechtner, J. et al. (2016). Immune responses elicited by the GEN-003 candidate HSV-2 therapeutic vaccine in a randomized controlled dose-ranging phase 1/2a trial. Vaccine. 34 (44), pp. 5314-5320. [Online]. 
  
Back to record